News & Updates
Filter by Specialty:
Soy isoflavones decrease frequency and duration of migraine attacks in women
A randomized controlled trial of reproductive-age women prone to migraines has shown soy isoflavones supplementation to be effective at reducing the frequency and duration of migraine attacks.
Soy isoflavones decrease frequency and duration of migraine attacks in women
09 Aug 2022
BP-lowering drug helps prevent Parkinson’s disease
Treatment with angiotensin receptor blockers (ARBs) appears to reduce the risk of Parkinson’s disease (PD) in patients newly diagnosed with hypertension, reports a recent study.
BP-lowering drug helps prevent Parkinson’s disease
08 Aug 2022
Cognition assessment important to ensure patient adherence to MS therapy
Adherence to disease-modifying therapies (DMT) in multiple sclerosis (MS) is dependent not only on the properties of the medications themselves, but also on the capacities of the patient, a recent study has found.
Cognition assessment important to ensure patient adherence to MS therapy
03 Aug 2022
White matter diminished in ASD teens born premature
In adolescents and young adults who screen positive for autism spectrum disorder (ASD), magnetic resonance imaging (MRI) reveals strong reductions in white matter, a new study has found.
White matter diminished in ASD teens born premature
29 Jul 2022
Could polyphenol intake affect Alzheimer’s disease risk?
The intake of certain polyphenols may be tied to a reduced risk of Alzheimer’s disease and related dementias (ADRDs) particularly in Black individuals, according to a study from the US presented at Nutrition 2022.
Could polyphenol intake affect Alzheimer’s disease risk?
28 Jul 2022
Secondary analysis boosts potential of atogepant for migraine prophylaxis in adults
In the secondary analysis of the phase III ADVANCE trial, responder rates were markedly higher with atogepant irrespective of dose than with placebo in adults with migraine.